Project Grant R01AI189326
Award Date 9/12/25
Completion Date 8/31/30
Dollars Obligated $769K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
- This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...
- This $658,019 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of the award is to establish a Rigorous, Rapid, and Relevant Evidence Adaptation and Implementation (R3EDI) Consultation Hub to support the Ending the HIV Epidemic (EHE) initiative. The R3EDI Hub will provide technical assistance, training resources, and consultation support to EHE...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel universal rapid test for HIV diagnosis. IGE Immunodiagnostics & Therapeutics, LLC, a minority-owned small business, will receive $294,948 to adapt their existing HIV ELISA test into a 5th generation antigen/antibody combination rapid test format. The goal is to create a simple, rapid,...
- This federal Project Grant award of $12,500,000 from the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914) will provide national training and technical assistance to address implementation barriers and improve HIV outcomes for disproportionately impacted populations. The award recipient, Georgetown University, will collaborate with partners including Boston University, Abt Global, and the Mayo Clinic to enhance technical...
- This Project Grant award, totaling $1,243,071.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant will fund the development of a new collaborative eligibility platform by Groupware Technologies, LLC (UEI: E8T9F94UU7D4) to support the application, determination, recertification, and enrollment processes for the Ryan White HIV/AIDS Program (RWHAP). The platform aims to increase linkage to care and retention...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and...
- This federal Project Grant award of $1,000,000.00 was provided by the Health Resources and Services Administration (HRSA) under the Special Projects of National Significance (SPNS) program (CFDA 93.928). The grant supports JSI Research & Training Institute Inc., a non-profit organization based in Boston, Massachusetts, in developing, implementing, and evaluating innovative strategies to improve HIV care, treatment, and support services for underserved populations. The funding will allow...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $108,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Kenyatta National Hospital (KNH) in Kenya. The purpose of this 2-year grant, with an award date of August 1, 2024 and a completion date of January 31, 2026, is to strengthen KNH's pre-award grants management capacity. The key products and services to be delivered through this funding include: 1) Training two senior research...
- This Project Grant award from the Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $621,999 to The University of Iowa to adapt and pilot test a multi-level, peer-led HIV prevention and stigma reduction intervention for adolescents in Western Kenya. The project aims to reduce HIV and sexual and reproductive health-related stigma, and increase HIV preventive behaviors among youth in the region. Key...